Hypercholesterolemia after conversion to sirolimus as primary immunosuppression and cardiac allograft vasculopathy in heart transplant recipients-Reference-Cited by-同舟云学术

Hypercholesterolemia after conversion to sirolimus as primary immunosuppression and cardiac allograft vasculopathy in heart transplant recipients

Published:2018-11 Issue:11 Volume:37 Page:1372-1380
ISSN:1053-2498
Container-title:The Journal of Heart and Lung Transplantation
language:en
Short-container-title:The Journal of Heart and Lung Transplantation

Author:

Asleh Rabea,Briasoulis Alexandros^ORCID,Pereira Naveen L.,Edwards Brooks S.,Frantz Robert P.,Daly Richard C.,Lerman Amir^ORCID,Kushwaha Sudhir S.

Publisher

Elsevier BV

Subject

Transplantation,Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference32 articles.

1. Allograft vasculopathy: the Achilles' heel of heart transplantation;Chih;J Am Coll Cardiol,2016

2. Cardiac allograft vasculopathy after heart transplantation: risk factors and management;Valantine;J Heart Lung Transplant,2004

3. The impact of steroid withdrawal on the development of lipid abnormalities and obesity in heart transplant recipients;Lake;J Heart Lung Transplant,1993

4. The effect of FK506 versus cyclosporine on glucose and lipid metabolism—a randomized trial;Steinmüller;Transplantation,1994

5. Impact of lipid abnormalities in development and progression of transplant coronary disease: a serial intravascular ultrasound study;Kapadia;J Am Coll Cardiol,2001

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiac Transplantation: Physiology and Natural History of the Transplanted Heart;Comprehensive Physiology;2023-06-26

2. Early immunomodulatory program triggered by pro-tolerogenicBifidobacterium pseudolongumdrives cardiac transplant outcomes;2022-10-16

3. Long-term efficacy of everolimus as de novo immunosuppressant on the cardiac allograft vasculopathy in heart transplant recipients;Atherosclerosis;2022-09

4. Low-Density Lipoprotein Cholesterol Level Trends and the Development of Cardiac Allograft Vasculopathy After Heart Transplantation;CJC Open;2021-12

5. Targeting peripheral immune organs with self‐assembling prodrug nanoparticles ameliorates allogeneic heart transplant rejection;American Journal of Transplantation;2021-07-19